[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1997

The Truth About Erythema Migrans

Author Affiliations

University of Connecticut Health Center 263 Farmington Ave Farmington, CT 06030

Arch Dermatol. 1997;133(1):93-94. doi:10.1001/archderm.1997.03890370099015
Abstract

LYME DISEASE in Europe and the United States is caused by different strains of the spirochete Borrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3 For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termed erythema chronicum migrans (ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States.

In this issue of the Archives, Hulshof and colleagues4 from the Netherlands report on the excellent outcome of 44 European patients

First Page Preview View Large
First page PDF preview
First page PDF preview
×